PDA Task Force Issues Guidelines to Aid Isolator Users

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-03-02-2002, Volume 26, Issue 3

When FDA reviewed PDA's Technical Report No. 34 about isolator systems, significant differences of opinion between the organizations came to light.

Related Content:

Aseptic/Sterile ProcessingManufacturingPackaging, Labeling, and Distribution SystemsEquipmentParenteralsFill-FinishDosage FormsManufacturing, Parenterals and InjectablesManufacturing, Liquid Drug ProductsManufacturing, Drug ProductsManufacturing Equipment, Fill-FinishPharmaceutical Technology-03-02-2002
With New Funding, Orbis Medicines to Develop Oral Macrocycles as Alternative to Biologic Drugs
Using Continuous Processes and Automation to Remove Contamination Risk
Takeda Receives Japanese Regulatory Approval for HYQVIA Subcutaneous Injection for Treating Agammaglobulinemia or Hypogammaglobulinemia